Kus, T. Et Al. 2015. Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib. ONCOTARGETS AND THERAPY , vol.8 , 3749-3756.

Kus, T., Aktas, G., Sevinc, A., KALENDER, M. E., YILMAZ, M., KUL, S., ... ÖZTUZCU, S.(2015). Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib. ONCOTARGETS AND THERAPY , vol.8, 3749-3756.

Kus, Tulay Et Al. "Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib," ONCOTARGETS AND THERAPY , vol.8, 3749-3756, 2015

Kus, Tulay Et Al. "Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib." ONCOTARGETS AND THERAPY , vol.8, pp.3749-3756, 2015

Kus, T. Et Al. (2015) . "Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib." ONCOTARGETS AND THERAPY , vol.8, pp.3749-3756.

@article{article, author={Tulay Kus Et Al. }, title={Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib}, journal={ONCOTARGETS AND THERAPY}, year=2015, pages={3749-3756} }